Pregled bibliografske jedinice broj: 651672
Extensive skin reactions during carbamazepin therapy
Extensive skin reactions during carbamazepin therapy // 1st International Conference on Creative Psychopharmacotherapy, 14th Central European Neuropsychopharmacological Symposium ; 6th croatian Congress of Psychopharmacotherapy
Dubrovnik, Hrvatska, 2013. str. .-. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 651672 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Extensive skin reactions during carbamazepin therapy
Autori
Juretić Pešćica, M ; Pavešić Radonja, A ; Knez, R.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
1st International Conference on Creative Psychopharmacotherapy, 14th Central European Neuropsychopharmacological Symposium ; 6th croatian Congress of Psychopharmacotherapy
/ - , 2013, .-.
Skup
1st International Conference on Creative Psychopharmacotherapy, 14th Central European Neuropsychopharmacological Symposium ; 6th croatian Congress of Psychopharmacotherapy
Mjesto i datum
Dubrovnik, Hrvatska, 25.09.2013. - 28.09.2013
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
carbamazepin; skin reactions; adverse effects
Sažetak
Objective: Although carbamazepin is relatively well tolerated, its rarest but most serious adverse effects, among others, are skin reactions. Clinical pictures of skin changes may alternate up to life-threatening dermatological syndromes like the Stevens-Johnson syndrome, where fatal outcomes may occur in up to 30% of the cases. Methods: A female patient was admitted to our Department of Psychiatry. The reason for admission was the worsening of her mental status in terms of present persecutory delusions and ideas of references. Atypical antipsychotic was introduced at first, and later the treatment with carbamazepin started. Four days after the initial dose of carbamazepin, skin alterations in the form of erythematic changes in area of the thorax, abdomen, groin, gluteus and upper leg, were develop. Results: Immediately after noticing skin changes the use of carbamazepin was stopped. After eight days since the beginning of the rash, of excluding carbamazepin and by using dermatological therapy, local skin exam showed complete resolution of the changes. Conclusion: According to the fact that skin changes developed soon after the introduction of carbamazepin, normality of laboratory results obtained after noticing it and since nothing else was changed in pharmacotherapy, we consider that the described skin changes are adverse events on carbamazepin. Dermatological therapy primarily was referring to “covering” possible diagnosis with such presentation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
